Pediatric formulation issues identified in Paediatric Investigation Plans

Expert Review of Clinical Pharmacology

Volumn 7, Issue 1, 2014, Pages 25-30

  Ruiz, Blanca Quijano ^a   Desfontaine, Emilie ^a   Arenas López, Sara ^b   Wang, Siri ^c  

^a EUROPEAN MEDICINES AGENCY   (United Kingdom)

^b EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^c Norwegian Medicines Agency   (Norway)

Author keywords

European Medicines Agency; excipients; Paediatric Committee; Paediatric Investigation Plans; pediatric formulations; pharmaceutical development

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; ALCOHOL; BENZYL ALCOHOL; CYCLODEXTRIN; EXCIPIENT; MANNITOL; POLYSORBATE 80; PROPYL PARABEN; PROPYLENE GLYCOL; SORBITOL;

ACCURACY; BODY WEIGHT; CHILD CARE; CLINICAL ASSESSMENT; DISEASE SEVERITY; DOSE CALCULATION; DRUG ADMINISTRATION ROUTE; DRUG CAPSULE; DRUG CONTROL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG INDUSTRY; HEALTH CARE ORGANIZATION; HUMAN; MEDICATION ERROR; PALATABILITY; PATIENT ATTITUDE; POWDER; PROCESS DEVELOPMENT; PRODUCT DEVELOPMENT; REVIEW; SUSPENSION; SYRUP; TABLET FORMULATION; TREATMENT DURATION;

AGE FACTORS; CHEMISTRY, PHARMACEUTICAL; CHILD; DRUG AND NARCOTIC CONTROL; DRUG INDUSTRY; EUROPE; EXCIPIENTS; HUMANS; PEDIATRICS; PHARMACEUTICAL PREPARATIONS;

EID: 84893093792     PISSN: 17512433     EISSN: 17512441     Source Type: Journal    
DOI: 10.1586/17512433.2014.857600     Document Type: Review

References (17)

1. Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004
2. Olski TM, Lampus SF, Gherarducci G, Saint Raymond A. Three years of paediatric regulation in the European Union. Eur. J. Clin. Pharmacol. 67, 245-252 (2011
3. Reflection paper: Formulations of choice for the paediatric population (EMEA/CHMP/ PEG/194810/2005
4. Nunn T, Williams J. Formulation of medicines for children. Br. J. Clin. Pharmacol. 59(6), 674-676 (2005
5. Polaha J, Dalton WT, Lancaster BM. Parental report of medication acceptance among youth: Implications for everyday practice. South. Med. J. 101(11), 1106-1112 (2008
6. Thomson SA, Tuleu C, Wong ICK, Keady S, Pitt KG, Sutcliffe AG. Minitablets: New modality to deliver medicines to preschool-Aged children. Pediatrics 123(2), e235-e238 (2009
7. Spomer N, Klingmann V, Stoltenberg I, Lerch C, Meissner T, Breitkreutz J. Acceptance of uncoated mini-Tablets in young children: Results from a prospective exploratory cross-over study. Arch. Dis. Child 97, 283-286 (2012
8. Klingmann V, Spomer N, Lerch C,. et al. Favorable acceptance of mini-Tablets compared with syrup: A randomized controlled trial in infants and preschool children. J. Pediatr. doi:10.1016/j. jpeds.2013.07.014 (2013) (Epub ahead of print
9. Van Riet-Nales DA, De Neef BJ, Schobben AFAM, Ferreira JA, Egberts TCG, Rademaker CMA. Acceptability of different oral formulations in infants and preschool children. Arch. Dis. Child. 98, 725-731 (2013
10. WHO. Report of the informal expert meeting on dosage forms of medicines for children. Presented at: 17th Meeting, Expert Committee on Selection and Use of Essential Medicines. WHO Headquarters, Geneva, Switzerland, 15-16 December 2008
11. James CE, Laing DG, Oram N. A comparison of the ability of 8-9-year-old children and adults to detect taste stimuli. Physiol. Behav. 62, 193-197 (1997
12. Mennella JA, Pepino MY, Reed DR Genetic and environmental determinants of bitter perception and sweet preference Pediatrics 115, e216-e222 (2005
13. Matsui D. Assessing the palatability of medications in children. Paediatric. Perinat. Drug Ther. 8, 55-60 (2007
14. Draft reflection paper on the use of methyland propylparaben as excipients in human medicinal products for oral use (EMA/ CHMP/SWP/272921/2012
15. Draft Guideline on the use of phthalates as excipients in human medicinal products (EMA/CHMP/SWP/362974/2012
16. Concept paper on the need for revision of the guideline on excipients in the label and package leaflet of medicinal products for human use (CPMP/463/00) (EMA/CHMP/ SWP/888239/2011
17. Guideline on pharmaceutical development of medicines for paediatric use (EMA/ CHMP/QWP/805880/2012 Rev. 2